Collagen Matrix, Inc. Receives FDA 510(k) Clearance of a Bioactive Moldable Bone Graft Matrix

OAKLAND, N.J. /PRNewswire/ -- Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based medical devices announced today the FDA 510(k) clearance of its innovative line of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix through its Spine business unit.

OssiMend® Bioactive Moldable Bone Graft Matrix is a perfect trio of anorganic carbonate apatite bone mineral, 45S5 bioactive glass and highly purified Type I collagen that can be molded into putty for filling irregular defect sites. The matrix is an osteoconductive, bioactive, porous implant that allows for bony ingrowth across the graft site. OssiMend® Bioactive Moldable is slowly resorbed and replaced by new bone tissue during the natural healing process. The matrix is available in various sizes including a unique 25cm long, 40cc strip for complex spine fusion surgeries. OssiMend® Bioactive Moldable joins the Company's wide range of implantable collagen and mineral based medical devices.

"We continue to expand our product portfolio for the Spine market with the development of this unique line of Bioactive bone graft matrices that combines a carefully-selected ratio of three powerful components. This innovative moldable version offers surgeons options for better ensuring predictable outcomes," said Bart J. Doedens, CEO of Collagen Matrix, Inc.  

 

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Collagen Matrix

Collagen Matrix, Inc., founded in 1997, delivers a full line of the highest-quality collagen and mineral based medical devices that support the body's natural ability to regenerate.  The Company currently manufactures finished medical devices represented by five business units—Dental, Spine, Orthopaedic, Dural Repair and Nerve Repair.  The evolution of the Company's leadership, proprietary technologies, manufacturing expertise and product portfolio has established a solid foundation for continued growth.  Opportunities continue to exist for collaboration through Product Distribution, Product Development and Contract Manufacturing.